Literature DB >> 26228900

Quantitative susceptibility mapping in patients with systemic lupus erythematosus: detection of abnormalities in normal-appearing basal ganglia.

Atsushi Ogasawara1, Shingo Kakeda2, Keita Watanabe1, Satoru Ide1, Issei Ueda1, Yu Murakami1, Junji Moriya1, Koichiro Futatsuya1, Toru Sato1, Shingo Nakayamada3, Kazuyoshi Saito3, Yoshiya Tanaka3, Tian Liu4, Yi Wang4, Yukunori Korogi1.   

Abstract

OBJECTIVES: To evaluate whether quantitative susceptibility mapping (QSM) can be employed to detect abnormalities within normal-appearing basal ganglia on conventional MRI in patients with neuropsychiatric systemic lupus erythematosus (NPSLE).
METHODS: For 33 SLE patients (13 NPSLE and 20 non-NPSLE patients) and 23 age/sex-matched controls, two radiologists independently measured the mean QSM and R2* values in various brain structures that appeared to be normal on conventional MR images. These values in each brain structure were compared among the two SLE groups and controls.
RESULTS: Regarding the putamen, the NPSLE patients showed significantly higher QSM values than the non-NPSLE patients and controls (p < 0.05). For the lateral globus pallidus, both SLE groups showed significantly higher QSM values than the controls (p < 0.05). The R2* values were not significantly different between both SLE groups. The NPSLE patients showed a significant correlation between the mean QSM values in putamen and the disease duration (r = 0.63, p < 0.05). For the interobserver agreement, the QSM value was superior to the R2* value (0.690 vs. 0.446, Kendall W value).
CONCLUSIONS: QSM can be used to identify increased susceptibility of the basal ganglia appearing to be normal on conventional MR images in NPSLE patients. KEY POINTS: • QSM values in the putamen are significantly higher in NPSLE than non-NPSLE. • NPSLE patients show correlation between QSM values in the putamen and disease duration. • QSM is more sensitive than R2* mapping for detecting subtle changes.

Entities:  

Keywords:  Basal ganglia; Iron; Neuropsychiatric systemic lupus erythematosus; Quantitative susceptibility mapping; R2*mapping

Mesh:

Year:  2015        PMID: 26228900     DOI: 10.1007/s00330-015-3929-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  41 in total

1.  Internal structures of the globus pallidus in patients with Parkinson's disease: evaluation with quantitative susceptibility mapping (QSM).

Authors:  Satoru Ide; Shingo Kakeda; Issei Ueda; Keita Watanabe; Yu Murakami; Junji Moriya; Atsushi Ogasawara; Koichiro Futatsuya; Toru Sato; Norihiro Ohnari; Kazumasa Okada; Atsuji Matsuyama; Hitoshi Fujiwara; Masanori Hisaoka; Sadatoshi Tsuji; Tian Liu; Yi Wang; Yukunori Korogi
Journal:  Eur Radiol       Date:  2014-11-01       Impact factor: 5.315

2.  Quantitative MR imaging of brain iron: a postmortem validation study.

Authors:  Christian Langkammer; Nikolaus Krebs; Walter Goessler; Eva Scheurer; Franz Ebner; Kathrin Yen; Franz Fazekas; Stefan Ropele
Journal:  Radiology       Date:  2010-09-15       Impact factor: 11.105

Review 3.  Imaging iron stores in the brain using magnetic resonance imaging.

Authors:  E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus
Journal:  Magn Reson Imaging       Date:  2005-01       Impact factor: 2.546

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.

Authors:  M Golstein; O Meyer; P Bourgeois; E Palazzo; P Nicaise; C Labarre; M F Kahn
Journal:  Clin Exp Rheumatol       Date:  1993 Jul-Aug       Impact factor: 4.473

6.  Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement.

Authors:  R Zivadinov; J L Shucard; S Hussein; J Durfee; J L Cox; N Bergsland; M G Dwyer; R H B Benedict; J Ambrus; D W Shucard
Journal:  Lupus       Date:  2013-05-02       Impact factor: 2.911

7.  Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.

Authors:  Bing Yao; Tie-Qiang Li; Peter van Gelderen; Karin Shmueli; Jacco A de Zwart; Jeff H Duyn
Journal:  Neuroimage       Date:  2008-11-05       Impact factor: 6.556

Review 8.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

9.  Neuropsychiatric systemic lupus erythematosus.

Authors:  Alexandra Popescu; Amy H Kao
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

10.  Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.

Authors:  Veela Mehta; Wei Pei; Grant Yang; Suyang Li; Eashwar Swamy; Aaron Boster; Petra Schmalbrock; David Pitt
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more
  8 in total

1.  Potential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson's disease.

Authors:  Mari Miyata; Shingo Kakeda; Yasuko Toyoshima; Satoru Ide; Kazumasa Okada; Hiroaki Adachi; Yi Wang; Yukunori Korogi
Journal:  Neuroradiology       Date:  2019-07-02       Impact factor: 2.804

2.  Quantitative susceptibility mapping of the motor cortex: a comparison of susceptibility among patients with amyotrophic lateral sclerosis, cerebrovascular disease, and healthy controls.

Authors:  Ji Young Lee; Young-Jun Lee; Dong Woo Park; Yoonho Nam; Seung Hyun Kim; Jinseok Park; Young Seo Kim; Hyun Young Kim; Ki-Wook Oh
Journal:  Neuroradiology       Date:  2017-10-11       Impact factor: 2.804

Review 3.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.

Authors:  Yi Wang; Pascal Spincemaille; Zhe Liu; Alexey Dimov; Kofi Deh; Jianqi Li; Yan Zhang; Yihao Yao; Kelly M Gillen; Alan H Wilman; Ajay Gupta; Apostolos John Tsiouris; Ilhami Kovanlikaya; Gloria Chia-Yi Chiang; Jonathan W Weinsaft; Lawrence Tanenbaum; Weiwei Chen; Wenzhen Zhu; Shixin Chang; Min Lou; Brian H Kopell; Michael G Kaplitt; David Devos; Toshinori Hirai; Xuemei Huang; Yukunori Korogi; Alexander Shtilbans; Geon-Ho Jahng; Daniel Pelletier; Susan A Gauthier; David Pitt; Ashley I Bush; Gary M Brittenham; Martin R Prince
Journal:  J Magn Reson Imaging       Date:  2017-03-10       Impact factor: 4.813

4.  Zebra sign of precentral gyri in amyotrophic lateral sclerosis: A novel finding using phase difference enhanced (PADRE) imaging-initial results.

Authors:  Shingo Kakeda; Tetsuya Yoneda; Satoru Ide; Mari Miyata; Tomoyo Hashimoto; Koichiro Futatsuya; Keita Watanabe; Atsushi Ogasawara; Junji Moriya; Toru Sato; Kazumasa Okada; Takenori Uozumi; Hiroaki Adachi; Yukunori Korogi
Journal:  Eur Radiol       Date:  2016-01-28       Impact factor: 5.315

5.  Structure Prior Effects in Bayesian Approaches of Quantitative Susceptibility Mapping.

Authors:  Shuai Wang; Weiwei Chen; Chunmei Wang; Tian Liu; Yi Wang; Chu Pan; Ketao Mu; Ce Zhu; Xiang Zhang; Jian Cheng
Journal:  Biomed Res Int       Date:  2016-12-20       Impact factor: 3.411

Review 6.  Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions.

Authors:  Kelly M Gillen; Mayyan Mubarak; Thanh D Nguyen; David Pitt
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

7.  Bilateral striopallidal calcinosis secondary to systemic lupus erythematosus.

Authors:  Juan Felipe Betancur; José A Goméz-Puerta; Juan Felipe Llano; Gustavo Adolfo Lopéz-Ochoa; Beatriz Ramirez; Oscar David Martinez
Journal:  Radiol Case Rep       Date:  2022-04-25

8.  Enlarged perivascular spaces are associated with the disease activity in systemic lupus erythematosus.

Authors:  Mari Miyata; Shingo Kakeda; Shigeru Iwata; Shingo Nakayamada; Satoru Ide; Keita Watanabe; Junji Moriya; Yoshiya Tanaka; Yukunori Korogi
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.